PubRank

Marla C Dubinsky

Author PubWeight™ 44.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011 5.58
2 Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010 4.65
3 Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 2009 2.36
4 Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol 2004 2.24
5 Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006 2.06
6 Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab. Am J Gastroenterol 2005 1.93
7 Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007 1.74
8 Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006 1.49
9 Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD. Inflamm Bowel Dis 2008 1.47
10 Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease. Inflamm Bowel Dis 2010 1.42
11 An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011 1.42
12 Significant variation in recommendation of care for women of reproductive age with ulcerative colitis postileal pouch-anal anastomosis. Dig Dis Sci 2014 1.40
13 Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011 1.24
14 Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey. Inflamm Bowel Dis 2009 1.19
15 Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013 1.15
16 A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014 1.15
17 A pilot study of adalimumab in infliximab-allergic patients. Inflamm Bowel Dis 2004 1.07
18 Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior. Inflamm Bowel Dis 2011 0.99
19 Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm Bowel Dis 2006 0.94
20 Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2014 0.94
21 The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey. Dig Dis Sci 2009 0.89
22 Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients. J Pediatr Gastroenterol Nutr 2011 0.88
23 Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol 2004 0.87
24 Variants in ZNF365 isoform D are associated with Crohn's disease. Gut 2011 0.87
25 Disease perceptions among people with Crohn's disease. Inflamm Bowel Dis 2008 0.86
26 Video capsule endoscopy impacts decision making in pediatric IBD: a single tertiary care center experience. Inflamm Bowel Dis 2013 0.83
27 Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies. J Clin Pharmacol 2015 0.80
28 Severe colitis in children. J Pediatr Gastroenterol Nutr 2005 0.78
29 Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy. Arch Pathol Lab Med 2004 0.78
30 Distinct phenotypes of children with perianal perforating Crohn's disease. J Pediatr Surg 2013 0.77
31 Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2016 0.75
32 Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use. Inflamm Bowel Dis 2016 0.75
33 Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe. Inflamm Bowel Dis 2017 0.75
34 The Evolving Role of Thiopurines for Inflammatory Bowel Disease. Inflamm Bowel Dis 2016 0.75
35 Probiotics in pediatric inflammatory bowel diseases. Curr Gastroenterol Rep 2009 0.75
36 Self-efficacy and Resilience Are Useful Predictors of Transition Readiness Scores in Adolescents with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2017 0.75
37 Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits. Inflamm Bowel Dis 2017 0.75
38 Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis. Inflamm Bowel Dis 2017 0.75
39 TNFRSF1B Is Associated with ANCA in IBD. Inflamm Bowel Dis 2016 0.75